Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Nov;208(5):631-8.
doi: 10.1097/00000658-198811000-00015.

Functional abnormalities of experimental autogenous vein graft neoendothelium

Affiliations

Functional abnormalities of experimental autogenous vein graft neoendothelium

K S Cross et al. Ann Surg. 1988 Nov.

Abstract

When a vein is grafted into the arterial circulation, the endothelium of the graft is damaged. Regeneration of an intact neoendothelium occurs, but the functional properties of this surface have not been clarified. In this study, the functional integrity of the neoendothelium of veins grafted into the carotid artery of the rabbit was assessed through the use of acetylcholine and histamine to stimulate the production of the important endothelium-derived relaxing factor (EDRF). Control veins, precontracted with norepinephrine [10(-5) M], relaxed after exposure to acetylcholine [( 10(-7) M], 42.4% +/- 6.4%, p = 0.008) and histamine [( 10(-6) M], 30.6% +/- 4.3%, p = 0.03). This relaxation response was abolished after mechanical removal of the endothelium. By contrast, neither acetylcholine nor histamine caused an endothelium-dependent relaxation in the vein grafts, even though scanning electron microscopy demonstrated the presence of a morphologically intact endothelium. However, addition of stabilized EDRF purified from cultured endothelial cells induced relaxation of the vein grafts (35.8% +/- 3.6%, p = 0.002). These data indicate that vein graft endothelium is unable to produce EDRF in response to exposure to acetylcholine or histamine. The inability to produce this potent smooth muscle cell relaxing factor and anti-aggregatory substance may be a predisposition to vein graft failure.

PubMed Disclaimer

References

    1. Ann Surg. 1985 Jul;202(1):50-5 - PubMed
    1. Chest. 1985 Apr;87(4):545-7 - PubMed
    1. Eur Heart J. 1986 Jan;7(1):4-13 - PubMed
    1. Nature. 1986 Apr 3-9;320(6061):454-6 - PubMed
    1. J Vasc Surg. 1987 Jan;5(1):126-36 - PubMed

Publication types

MeSH terms